Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 14 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (5)
Early P 1 (1)
P 1 (2)
P 2 (3)
P 3 (1)

Trial Status

Recruiting7
Active Not Recruiting3
Completed3
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT06479811Phase 1Recruiting

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

NCT07828704Phase 2RecruitingPrimary

Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA

NCT07820566RecruitingPrimary

Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)

NCT07527637Active Not Recruiting

Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer

NCT06745609Not ApplicableActive Not Recruiting

Prehabilitation Prior to Surgery for Kidney Tumors

NCT07300241Phase 1Recruiting

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NCT07713654Not ApplicableCompletedPrimary

Tumor Heterogeneity of Renal Tumors Assessed by Multiparametric MRI With Direct Radiological-histopathological Correlation: an Explorative Study

NCT07624578Not ApplicableWithdrawnPrimary

Evaluation of 68Ga-PSMA PET-CT in the Initial Staging of Advanced Renal Cell Carcinomas - A Prospective, Multicentre, Open-label Study

NCT07590310Early Phase 1RecruitingPrimary

Clinical Application of CAIX-Targeted PET Imaging in Tumors

NCT07568444Phase 2Completed

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

NCT07050771Phase 2Recruiting

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

NCT07413120Phase 3Completed

Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery

NCT07171190Not ApplicableRecruiting

Targeted Abdominal CT in Conjunction With Lung Cancer Screening

NCT07173140Not ApplicableActive Not Recruiting

Renal Tumour Imaging Using MRI

Showing all 14 trials

Research Network

Activity Timeline